Cargando…
Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities
Esophageal squamous cell carcinoma (ESCC) is one of the common malignant tumors in the world. More than half of patients with ESCC were detected in advanced or metastatic disease at the time of initial diagnosis and lost the opportunities of surgery. Currently, surgical resection, radiotherapy, and...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677374/ https://www.ncbi.nlm.nih.gov/pubmed/31551657 http://dx.doi.org/10.2147/OTT.S214579 |